What to Expect Before, During, and After Endometriosis Surgery

Surgery for endometriosis (and often adenomyosis alongside it) can feel daunting: you may be hoping for pain relief, answers, or a path toward pregnancy—while also worrying about complications, time off work, and whether symptoms will come back.

This article walks you through what typically happens before, during, and after endometriosis surgery, using insights from multiple recent studies—especially research focused on deep infiltrating endometriosis (DIE) involving the bowel/rectovaginal space, where surgery is more complex and planning matters a lot.

Because endometriosis surgery isn’t one “standard procedure,” your experience depends on where disease is located (ovaries vs bowel vs bladder), how extensive it is, your goals (pain relief vs fertility), and your surgeon/team. It is rather common during surgery to find more than imaging suggested.

Before surgery: getting the clearest map possible

Expect imaging—but know what each test is best at

Most people have some form of imaging before surgery, and for suspected DIE, the two workhorses are transvaginal ultrasound (TVUS) and MRI. A 2025 systematic review comparing MRI vs TVUS found both tests can be highly accurate for rectosigmoid (bowel) DIE, with sensitivity commonly in the ~80–90% range for both and high specificity as well. In other words: if bowel DIE is the main concern and the scan is performed by an experienced team, either test may help identify it.

Where the differences show up is in harder-to-see locations. That same review found TVUS performance can be more variable for uterosacral ligament lesions and for bladder/anterior disease, while MRI was often more sensitive for these areas and may be better for multi-compartment mapping. Practically, that means:

• If your ultrasound is “normal” but your symptoms strongly suggest DIE (especially bladder/anterior symptoms or pain patterns suggesting uterosacral involvement), your surgeon may reasonably recommend MRI rather than simply accepting what may be inaccurate ultrasound findings.
• Imaging is less about “do I have endometriosis?” than it is about shaping the surgical plan.

Expect your surgeon to talk about “complexity” (and why that matters)

You may hear staging or classification terms like rASRM, AAGL2021, or #Enzian. While these labels don’t predict exactly how you’ll feel after surgery, they can help teams anticipate operative complexity. Unfortunately, all of these staging systems are poor to moderate, at best, in predicting what will actually be found during surgery. But a 2025 study looking at classification systems found higher stages/specific #Enzian compartment involvement correlated with longer operative time—a practical proxy for how involved surgery may be. The higher the anticipated stage, the longer the surgery will likely be.

Why you should care as a patient: complexity affects things you’ll feel in real life—how long you’re under anesthesia, whether multiple specialists are present, how likely you are to need a hospital stay, and what kinds of risks should be discussed clearly in advance. Having said that, some cases are anticipated to be minimally complex and end up taking many hours to complete appropriately.

Expect planning for the right team—not just the right date

One of the most patient-relevant points from the MRI vs TVUS review is that imaging can improve surgical decision-making, such as whether colorectal or urologic specialists should be involved. In one included study, adding MRI improved correct multidisciplinary team assignment substantially.

If you suspect bowel endometriosis, one of the most important “before surgery” expectations is that your surgeon should be able to tell you:

• whether bowel involvement is expected,
• whether a colorectal surgeon will be present,
• and what bowel procedures are potentially planned (from shaving to disc excision to segmental resection).

Pre-op medical treatment: will you be asked to take a GnRH agonist first?

Some surgeons recommend GnRH agonists (GnRHa) for a few months before operating, especially for rectovaginal/colorectal endometriosis. Two large multicenter cohort studies published in 2025 provide a nuanced message that’s important for informed consent: there may be symptom control advantages—but also higher complication odds in these datasets.

Possible mechanisms could include tissue fibrosis from hormonal suppression making surgical planes more difficult to identify, or altered tissue characteristics affecting healing. The "nuanced message" is that while some surgeons advocate preoperative GnRH agonist use based on theoretical benefits and symptom control, patients should understand the evidence is mixed regarding surgical outcomes and complications, particularly for complex deep infiltrating disease requiring bowel surgery.

For DIE and rectovaginal/colorectal endometriosis specifically, the informed consent discussion should address:

• Preoperative GnRH agonists may provide symptom relief during the surgical wait period, but at a potential complication increased risk
• Evidence for improved surgical outcomes is limited and potentially contradictory
• Postoperative GnRH agonist therapy has clearer benefits for reducing recurrence but there are numerous reasons to avoid GnRH therapy due to a myriad of short and long term morbidities
• Alternative first-line hormonal options (combined contraceptives, progestins) have similar pain relief efficacy with fewer adverse effects and lower cost 

Given that a number of surgeons, not all of whom are endometriosis specialists, advise this strategy, here are the data:

What you might gain: symptom improvement (especially in the first year)

In one multicenter cohort focused on symptoms after rectovaginal/colorectal endometriosis surgery, people who used pre-operative GnRHa tended to have better improvement in several pain symptoms (like menstrual pain and non-cyclical pelvic pain) and certain bowel symptoms up to about 12 months. Some differences faded by 24 months, suggesting that if there is added benefit, it may be most noticeable in the short- to mid-term rather than permanently.

Not every symptom followed this pattern. For example, dyspareunia did not show a clear additional benefit linked to pre-op GnRHa in that study, and bladder symptom findings were mixed—once the researchers adjusted for confounders, bladder outcomes looked more similar between groups.

What you might risk: higher odds of certain complications (in these observational data)

A separate (also multicenter) 2025 cohort study focused on surgical outcomes reported that pre-operative GnRHa use was associated with higher odds of perioperative complications overall, and—after adjustment for several factors—higher odds of specific complications such as pelvic hematoma and pelvic abscess. It also reported a higher adjusted odds of colostomy in the pre-op GnRHa group.

This does not prove GnRHa causes these complications (these weren’t randomized trials, and people selected for GnRHa may have had more severe disease in ways the database couldn’t fully capture). But from a patient standpoint, it does mean: if someone recommends pre-op GnRHa, you deserve a clear explanation of why in your case, and a transparent conversation about risks.

What to expect if you do take GnRHa

Many patients experience menopausal-type side effects (hot flashes, vaginal/genital dryness, mood or sleep changes). Bone density concerns can matter with longer use, and some clinicians use “add-back therapy” to make side effects more tolerable. Also, the studies above reflect real-world practice where exact dosing/duration may vary—so your individual regimen could look different.

Preoperative preparation and the Early Recovery After Surgery program (ERAS®)

ERAS^® is a key component that unfortunately only about half the surgeons in this country use to improve outcomes. It has its origins in big incisional surgery but for the following reasons occupies a central place for endo surgery.

Patients with endometriosis present unique preoperative challenges including chronic inflammation, immune dysregulation, and potential relative energy deficiency (RED-S)—all of which can impair surgical healing and increase recurrence risk. Multimodal prehabilitation incorporating nutrition, exercise, and psychological support has demonstrated a 50% reduction in severe complications in major abdominal surgery, with outcomes improving proportionally to the number of ERAS elements implemented. 

Key Preoperative Elements:

• Patient education: Counseling on surgical process, recovery timeline, and disease-specific expectations, beyond just the nuts and bolts of the procedure
• Nutritional screening: Identify at-risk patients; consider LEAF-Q screening for athletic populations with potential RED-S and address
• Protein supplementation: 1.2–1.5 g/kg/day for 1–2 weeks in malnourished or at-risk patients  (e.g. malnourishment is often found in associated MALS)
• Anti-inflammatory diet: Mediterranean pattern, omega-3s, antioxidants; limit processed foods and red meat 
• Carbohydrate loading: Complex carbohydrate drink 2–6 hours preoperatively to reduce insulin resistance and anxiety
• Liberalized fasting: Clear fluids until 2 hours, solids until 6 hours before anesthesia 
• No mechanical bowel preparation in most: No proven benefit; burdensome for patients with baseline GI symptoms (there are exceptions)
• Anemia correction: Essential given frequent heavy menstrual bleeding in this population

This is just an introductory list but you get the idea. There is a lot of detail that should go into perioperative care which optimizes outcomes and can be expanded even further using an integrative holistic program. At Lotus Endometriosis Institute, for example, it is called ERAS+.

The day of surgery: what typically happens

Even though endometriosis surgeries vary, many follow a familiar rhythm:

You’ll check in, meet anesthesia, and review the plan. Ideally you will have had the opportunity to speak to the anesthesiologist the night before. If DIE is suspected, you may see more than one surgical team. Your operation may include:

• Excision of endometriosis from various sites
• Ovarian endometrioma surgery (cystectomy)
• Adhesiolysis
• Possible bowel, bladder, or ureter work depending on disease

A key “during surgery” expectation: the final plan sometimes changes based on what’s found. That’s why pre-op mapping and clear consent discussions are crucial.

Antibiotics: will you get them?

Many patients assume antibiotics are automatic. In reality, practice varies depending on what’s planned (especially whether bowel is entered (any area of bowel, including an appendectomy), a hysterectomy is done, or there is vaginal entry).

A 2026 study evaluating prophylactic antibiotics in minimally invasive endometriosis surgery (excluding certain higher-risk procedures like bowel resection and hysterectomy/colpotomy) found postoperative infections within 30 days were rare overall. Importantly, in that center, surgeons tended to give antibiotics to patients with more complex surgery, which makes it hard to interpret simple “antibiotics vs no antibiotics” comparisons.

What you can take from this as a patient: antibiotic decisions are often risk-stratified, and it’s reasonable to ask what drives your surgeon’s choice and what infection warning signs they want you to watch for.

After surgery: a realistic recovery timeline

The first 72 hours: pain control and “what’s normal”

Expect incisions to be sore and fatigue to be significant. Many people also experience shoulder pain from laparoscopic gas (even though best efforts are made to evacuate the gas after surgery) and constipation from anesthesia/opioids.

If you had bowel or bladder procedures, pain control and diet progression may be different than after a straightforward surgery. This is also where the “complexity” discussed pre-op shows up as real differences in recovery.

The first 2 weeks: swelling, bowel function, and activity limits

Many patients underestimate how much internal healing is happening even with tiny incisions. A common recovery pattern is “I look okay, but I don’t feel okay yet.” Walking is usually encouraged early, but lifting or engaging you core limits are common.

If you had surgery for rectovaginal/colorectal endometriosis, bowel habits may fluctuate for a while. Because research in this area often tracks bowel symptoms long-term, it’s worth knowing that symptom improvement (when it happens) may unfold over months—not days.

Weeks 3–6: returning to work and daily routines

Return-to-work timing varies widely:

• Desk-based work may be possible earlier for some people.
• Physically demanding jobs often require more time.

If you had ovarian surgery (endometrioma), you might also discuss when to re-check ovarian reserve markers if fertility planning is a goal.

Months 3–12: where many people notice the “real” outcome

This is the window where many studies assess symptom outcomes and aligns with what many patients experience: improvement can be gradual and sometimes uneven. In other words there may be twinges of discomfort that is similar or different from what it was before surgery but will taper off in most cases. This is because internal healing lasts at least 3-4 months.

Ovarian endometrioma surgery: what to expect if removing an endometrioma is part of your plan

If you have an ovarian endometrioma, your surgeon may discuss different technical approaches to cyst removal. A 2026 study evaluating volumetric hydrodissection during endometrioma stripping found it did not clearly improve short-term outcomes like pain scores or AMH drop compared with classic stripping or sharp excision, and long-term reproductive outcomes (over years of follow-up among respondents) looked similar. It did, however, appear to help surgeons remove the cyst intact more often and affected specimen characteristics in a potentially tissue-sparing direction.

Patient-centered takeaway: technique details may matter for surgical handling, but you shouldn’t assume a specific technique guarantees better fertility outcomes based on current evidence. The main thing is that the surgeon is aware of the notion of minimizing trauma and scarring on the ovary.

Long-term expectations: recurrence risk and how to reduce it

A common fear is: “What if it all comes back?” Long-term data are sobering but also useful for planning. A 2025 follow-up study (6–12 years) after laparoscopic excision of deep infiltrating endometriosis found recurrence increased over time—roughly 7% by 6 years and 14% by 12 years using that study’s definition. Some report much higher figures, especially when endometrioma is part of the picture.

It also identified patterns that can inform follow-up conversations:

• Younger age at surgery was linked with higher recurrence risk. (mostly related to more time in the long run for recurrence to materialize)
• A left-sided ovarian endometrioma was a strong risk factor in that cohort (it can be harder to remove by a less experienced surgeon).
• Postoperative GnRH-a use for 6 months was associated with lower recurrence compared with shorter/no use. (but similar data for kinder and gentler hormonal management using progestogens)
• Pregnancy after surgery was also associated with lower recurrence risk (an association, not a recommendation to pursue pregnancy as treatment).

This is one of the clearest “after surgery” messages supported across modern practice: postoperative medical management and long-term monitoring matter, especially for DIE and endometriomas.

Practical takeaways: questions to ask your surgeon

• “Based on my imaging and symptoms, what sites are you most concerned about (bowel, bladder, ureter, ovaries, uterosacral ligaments)?”
• “Will I have TVUS, MRI, or both—and is the scan being done with an endometriosis-focused protocol?”
• “Do you use a classification system like #Enzian or AAGL2021 for planning, and what does mine imply for surgical complexity?”
• “Will a colorectal or urologic surgeon be present if needed? What bowel/bladder procedures might be needed?”
• “Are you recommending pre-operative GnRH agonist? What benefit are you aiming for in my symptom profile—and what complications should we discuss?”
• “What is your plan for postoperative suppression to reduce recurrence risk, and when would we start?”
• “What warning signs after surgery mean ‘call today’ vs ‘go to the ER’ (especially fever, worsening pain, heavy bleeding, trouble peeing, or signs of infection)?”

What we still don’t know

Even the strongest studies have limits that matter to patients. Much of the evidence about pre-op GnRHa and outcomes in complex DIE surgery comes from observational cohorts, not randomized trials—so confounding (sicker patients getting certain treatments) can’t be fully excluded. Imaging accuracy varies based on operator skill and protocol, and classification systems correlate with operative time but don’t tell you exactly how you’ll feel afterward.

Finally, endometriosis often overlaps with adenomyosis, pelvic floor dysfunction, IBS-like symptoms, and pain sensitization. Those factors can strongly influence recovery and symptom relief, yet aren’t consistently captured in surgical databases—one reason two people can have “the same surgery” and very different outcomes.

The most useful expectation to carry into endometriosis surgery is this: the best results usually come from good mapping, preoperative optimization, the right surgeon +/- team, clear consent about tradeoffs, and a long-term plan after surgery—not just the operation itself.